Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary

Reuters

16 May

Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary

Longevity Health Holdings Inc. (Nasdaq: XAGE) has announced a significant merger agreement with 20/20 BioLabs. Executed on April 11, 2025, the agreement outlines that 20/20 BioLabs will become a wholly owned subsidiary of Longevity Health Holdings, contingent upon the fulfillment of specific conditions in the agreement. This strategic move is anticipated to enhance Longevity Health Holdings' focus on extending human longevity and healthy aging, leveraging 20/20 BioLabs' expertise and customer base. The merger reflects Longevity Health Holdings' ongoing commitment to innovation in regenerative bio-aesthetics, diagnostics, and nutrition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-072931), on May 16, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2535640493"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535640493\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2535640493?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-16 18:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535640493","market":"us","top_or_hot":-1,"title":"Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Longevity Health Holdings Inc. (Nasdaq: XAGE) has announced a significant merger agreement with 20/20 BioLabs. Executed on April 11, 2025, the agreement outlines that 20/20 BioLabs will become a wholly owned subsidiary of Longevity Health Holdings, contingent upon the fulfillment of specific conditions in the agreement. This strategic move is anticipated to enhance Longevity Health Holdings' focus on extending human longevity and healthy aging, leveraging 20/20 BioLabs' expertise and customer base. The merger reflects Longevity Health Holdings' ongoing commitment to innovation in regenerative bio-aesthetics, diagnostics, and nutrition.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-072931), on May 16, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLongevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-16 18:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Longevity Health Holdings Inc. (Nasdaq: XAGE) has announced a significant merger agreement with 20/20 BioLabs. Executed on April 11, 2025, the agreement outlines that 20/20 BioLabs will become a wholly owned subsidiary of Longevity Health Holdings, contingent upon the fulfillment of specific conditions in the agreement. This strategic move is anticipated to enhance Longevity Health Holdings' focus on extending human longevity and healthy aging, leveraging 20/20 BioLabs' expertise and customer base. The merger reflects Longevity Health Holdings' ongoing commitment to innovation in regenerative bio-aesthetics, diagnostics, and nutrition.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-072931), on May 16, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL7QNM1N:1","article_id":"2535640493","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535640493","pubTimestamp":1747389700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Longevity Health Holdings Inc.  has announced a significant merger agreement with 20/20 BioLabs. Executed on April 11, 2025, the agreement outlines that 20/20 BioLabs will become a wholly owned subsidiary of Longevity Health Holdings, contingent upon the fulfillment of specific conditions in the agreement. This strategic move is anticipated to enhance Longevity Health Holdings' focus on extending human longevity and healthy aging, leveraging 20/20 BioLabs' expertise and customer base. The merger reflects Longevity Health Holdings' ongoing commitment to innovation in regenerative bio-aesthetics, diagnostics, and nutrition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","XAGE":"Longevity Health Holdings, Inc."},"translate_title":"Longevity Health Holdings Inc.宣布与20/20 BioLabs达成合并协议，将成为全资子公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAGE":0.9},"content_text":"Longevity Health Holdings Inc. Announces Merger Agreement with 20/20 BioLabs, Set to Become Wholly Owned Subsidiary\n    \n\n        Longevity Health Holdings Inc. (Nasdaq: XAGE) has announced a significant merger agreement with 20/20 BioLabs. Executed on April 11, 2025, the agreement outlines that 20/20 BioLabs will become a wholly owned subsidiary of Longevity Health Holdings, contingent upon the fulfillment of specific conditions in the agreement. This strategic move is anticipated to enhance Longevity Health Holdings' focus on extending human longevity and healthy aging, leveraging 20/20 BioLabs' expertise and customer base. The merger reflects Longevity Health Holdings' ongoing commitment to innovation in regenerative bio-aesthetics, diagnostics, and nutrition.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-072931), on May 16, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}